carbon tetrachloride has been researched along with montelukast in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Căruntu, ID; Crauciuc, E; Cuciureanu, M; Jerca, L; Nechifor, M; Păduraru, O; Stoica, B | 1 |
| Cao, F; Pu, S; Ren, C; Wang, Y; Wu, Y; Yang, S; Zhang, J; Zhou, H | 1 |
4 other study(ies) available for carbon tetrachloride and montelukast
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The protective effect of montelukast sodium on carbon tetrachloride induced hepatopathy in rat.
Topics: Acetates; Alanine Transaminase; Animals; Bilirubin; Carbon Tetrachloride; Catalase; Chemical and Drug Induced Liver Injury; Cyclopropanes; Liver; Liver Diseases; Male; Malondialdehyde; Quinolines; Rats; Rats, Wistar; Sulfides; Superoxide Dismutase | 2009 |
Montelukast prevents mice against carbon tetrachloride- and methionine-choline deficient diet-induced liver fibrosis: Reducing hepatic stellate cell activation and inflammation.
Topics: Animals; Carbon Tetrachloride; Diet; Fibrosis; Hepatic Stellate Cells; Humans; Inflammation; Liver; Liver Cirrhosis; Methionine; Mice; Racemethionine; Signal Transduction; Transforming Growth Factor beta1 | 2023 |